During a tavr procedure using a 23mm sapien 3 ultra valve via transfemoral approach, the balloon was slightly misaligned by 1mm.The team decided to still deploy the valve, the balloon ruptured before the extra cc could be pushed in.The team was able to remove the balloon without issue and post-dilated dilated with a new 23mm delivery system +1cc.No patient injury was reported.
|
Correction to h6; component code, type of investigation, investigation findings, investigation conclusion.The 23mm commander delivery system (ds) was not returned for examination.Due to the unavailability of the complaint device, engineering was unable to perform any visual inspection, functional testing, or dimensional analysis.The 3mensio imagery showed calcification present within the patient's aortic root.A device history record (dhr) review was performed and did not reveal any manufacturing nonconformance issues that would have contributed to the event.A lot history review was performed and revealed no other complaints relating to the complaint code.The following instructions for use (ifu) were reviewed: commander delivery system, device preparation training manual, and the procedural training manual.Based on this review, no ifu/training deficiencies were identified.A review of edwards lifesciences risk management documentation was performed for this case.The reported event is an anticipated risk of the transcatheter heart valve procedure, additional assessment of the failure mode is not required at this time.The reported event of balloon burst and valve not between alignment markers were unable to be confirmed as no device or relevant imagery showing the misaligned valve and balloon burst during deployment was provided.Due to the unavailability of the device, engineering was unable to perform any visual, functional, or dimensional analysis; therefore, a manufacturing non-conformance was unable to be determined.Additionally, a review of the dhr and lot history did not provide any indication that a manufacturing non-conformance would have contributed to the complaint.A review of the ifu and training manuals revealed no deficiencies.Furthermore, no abnormalities were reported during device preparation or valve alignment.The complaint description states, "the team decided to still deploy the valve, the balloon ruptured before the extra cc could be pushed in".Additionally, per the 3mensio review, calcification was present within the patient's aortic root.The balloon burst could be potentially from multiple factors (i.E.Calcified annulus/leaflets, additional inflation volume, and previous implanted valve).While the balloons are sufficiently designed and tested to ensure the burst pressure is at or above the rated burst pressure, calcified nodules can compromise the structure of the balloon wall via the following mechanisms such as puncture, local overstretching, open cell impingement, or stress concentration.
|